Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 1.53 g/t Au over 191.3m in infill drilling at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Sol Gel Technologies Ltd SLGL

Healthcare Biotechnology
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SLGL)

Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire November 20, 2025

Sol-Gel Announces Health Canada Approval of EPSOLAY®

GlobeNewswire September 4, 2025

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

GlobeNewswire August 15, 2025

Sol-Gel Reports First Quarter 2025 Results

GlobeNewswire May 23, 2025

Sol-Gel Announces Reverse Share Split

GlobeNewswire May 1, 2025

Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.

GlobeNewswire April 17, 2025

Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement

GlobeNewswire November 20, 2024

Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire November 15, 2024

UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire August 17, 2024
View More News ››

Opinion & Analysis (NDAQ:SLGL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SLGL)

Be the first to post on this bullboard.

AJA Health and Wellness Inc

AJA Health and Wellness Inc

AJA Health and Wellness Inc. operates a telemedicine platform and full-service travel clinics. The company offers virtual ...
View More »